CHI SHENG PHARMA & BIOTECH CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 4111 for the last quarter is 267.20 M TWD, and it's 1.02% lower compared to the previous quarter. The net income of Q1 24 is 23.13 M TWD.